Skip to main content

NIH Calls for Input on Prioritizing Development of Affinity Reagents to Transcription Factors

Premium

The National Institutes of Health this week put out a call for input on a priority list for renewable affinity reagents for human transcription factors.

The outreach is part of the NIIH's Protein Capture Reagents Program, which is intended to determine if a source of high-quality, renewable affinity reagents can be generated and validated for all human proteins and to build technologies for doing so.

As a test case, the program seeks to generate affinity reagents against all human transcription factors.

The program's Target List working group has identified a list of targets to begin production of affinity reagents against and is now seeking input from researchers about the list and assistance in validation of these reagents for a variety of applications and CHiP-seq in particular.

Comments can be contributed through Oct. 31, and can be made here.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.